$SSL

Sasol expects higher earnings with R16.8bn in pre-tax impairments

Sasol said its trading statement for the year ended 30 June 2026 expects EPS of R17.50 to R19.50 versus R10.60 in 2025, HEPS of R36 to R40 versus R35.13, and adjusted EBITDA of R58 to R62 billion versus R51.8 billion. The company cited higher sales volumes, Brent prices and refining margins, plus lower impairments of R16.8 billion (vs R20.7 billion), partly offset by a stronger rand and other items. Results are due 1 Sept 2026.

Original reporting
Published Aug 10, 2026, 6:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SSL
Bullish
medium confidence
Mentioned
$SSL
Relevance
9/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SSLBullishHigh
01

Why it matters

The guidance includes quantified drivers (volume, Brent, refining margins) and quantified headwinds (rand strength, impairments totaling R16.8bn, unrealised derivative losses, and working-capital drag). This can change near-term expectations for earnings quality and cash conversion ahead of audited results.

02

Market read

Traders can update models immediately using the new EPS and adjusted EBITDA ranges and the impairment and working-capital disclosures, then reassess risk into the 1 Sep 2026 results.

03

What to watch

The Secunda CGU remains fully impaired, and the stronger rand both reduces reported earnings and affects recoverable amounts, so upside may be less durable if FX and long-term price assumptions move against the company.

Relevance 9/10Novelty 8/10Timing: pre-results, ahead of 1 Sep 2026 audited results

Background

Sasol released an unaudited trading statement for the year ended 30 June 2026, setting forward guidance and explaining drivers versus the prior year.

Company-level read

Ticker impact

$SSLBullishMedium confidence
Context

Sasol (SSL) issued a trading statement guiding FY26 EPS to R17.50-R19.50 and adjusted EBITDA to R58-R62 billion.

Expected impact

Near-term repricing likely toward the upside on the guidance beat narrative, tempered by impairment and free-cash-flow concerns.

Evidence & confidence

The article provides specific forward-looking ranges (EPS, HEPS, adjusted EBITDA) and quantifies key offsets (R16.8bn impairments, stronger rand, working capital), which are direct inputs to valuation and sentiment ahead of the 1 Sep results.

Market effects

Reinforces the sensitivity of integrated refiners to Brent differentials and refining margins, while highlighting impairment risk tied to FX and long-term price assumptions.

May influence South Africa energy and industrial sentiment via rand-linked earnings sensitivity and impairment disclosures.

Provides a datapoint on refining margin strength and impairment mechanics for global commodity-linked chemical and fuels producers.

Counterpoint

The headline earnings rebound is partly offset by new impairments (Polyethylene and Mozambique PSA) and elevated working capital that could limit free cash flow despite higher adjusted EBITDA.

Key entities

  • Sasol

    Guided FY26 EPS, HEPS, and adjusted EBITDA ranges and disclosed impairment details and offsets.

  • Simon Baloyi

    CEO referenced as hosting the market call after the audited results release.

  • Walt Bruns

    CFO referenced as hosting the market call after the audited results release.

Related articles

$SSLMedAI 8/10

The South African company thriving on the US-Israeli war on Iran

Sasol, the South African energy and chemicals company, said in a trading statement it expects FY earnings per share of R17.50 to R19.50, up 65% to 84% from R10.60 a year earlier, as oil and fuel prices rose after US and Israel strikes on Iran and Strait of Hormuz disruptions. Adjusted EBITDA is forecast at R58-62 billion versus R51.8 billion.

$SSLMed

Sasol’s wartime windfall revives debate over coal’s future

Sasol said it expects EBITDA of up to R62 billion for the year ended June 30, up from R52 billion a year earlier, citing higher fuel prices linked to the Iran war. CEO Simon Baloyi highlighted increased coal-to-liquids and refinery output, renewable buildout, and a 30% emissions cut by 2030. Sasol’s Oryx gas-to-liquids output was halted after the conflict began.

$SSLMed

Sasol flags fuel margins boost, easing writedowns

Sasol said it expects headline EPS to rise 2% to 14% for the year to June, after R22.4bn in the prior year, as profit gains from higher volumes offset easing writedowns. Adjusted EBITDA is forecast at R58bn to R62bn, up to 20%, helped by a 4% volume rise and improved fuel differentials. Impairments before tax are expected at R16.8bn. Full-year results are due 1 Sep.

$SSLMed

Sasol’s Secunda plant posts strongest output in five years

Sasol said its Secunda plant produced its highest annual output in five years after its coal-destoning facility improved coal quality. The company expects performance to stay within or above guidance and said 2026 results are supported by stronger output and a better macro backdrop. Chemicals and energy units also beat expectations. Full-year results are due Sept. 1.

$SSLHighAI 9/10

Sasol’s blistering rally meets growing scepticism from analysts

Sasol shares have doubled in 2024, helped by higher oil prices after the Iran conflict, with Brent up 36% since the start of the war. Bloomberg data show only two buy ratings remain out of nine after downgrades by Nedbank and Citigroup. Analysts cite limited upside, carbon liabilities from coal-heavy operations, and risks around Secunda’s value and potential terminal decline.

$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.